Precision in Diagnosing and Classifying COPD: Comparison of Historical Height with Current Height and Arm Span to Predict FEV(1)
- PMID: 22896775
- PMCID: PMC3415627
- DOI: 10.2174/1874306401206010054
Precision in Diagnosing and Classifying COPD: Comparison of Historical Height with Current Height and Arm Span to Predict FEV(1)
Abstract
Background: Measured reductions in lung function, as a result of COPD, use a measured current value and make comparisons to a determined 'normal' value arrived at using a regression equation based upon a patients height. Osteoporosis is a recognised co-morbidity in patients with chronic obstructive pulmonary disease (COPD) and may cause excessive height loss resulting in the 'normal' values and disease progression being under-estimated.
Purpose: The aim of the study was to examine the height variation in a cohort of COPD patients and controls over a 7-8 years period and evaluate its impact on estimates of lung function and hence COPD progression.
Methods: In 1999-2002 we studied a cohort of primary care patients in Sunderland, UK with and without COPD and reexamined 104 (56 male) during 2007-2009. We calculated FEV(1)% predicted for actual and estimated height (armspan/1.03 and armspan/1.01 in males and females respectively).
Results: In 1999-2002 the subjects were aged 62.6 ± 9.4 years, BMI was 26.4± 4.7 kg/m2, predicted FEV(1) was 59.0 ±16.0, and mean actual height was 167.3±8.9cm. The actual height changed significantly (p<0.001) by 2cms over time in both genders. Whilst the overall classifications of the cohort did not change significantly when armspan was used to determine height and hence normal lung volume, individual cases did move to a classification of higher severity.
Conclusions: The study suggests that current measured height may underestimate the degree of impairment of FEV(1) and hence progression of COPD. The use of height, derived from armspan, may give a more accurate measure of 'normal' lung volumes and hence the degree of impairment.
Keywords: Chronic obstructive pulmonary disease; historical height; osteoporosis..
Figures



Similar articles
-
Impact of direct substitution of arm span length for current standing height in elderly COPD.Int J Chron Obstruct Pulmon Dis. 2015 Jun 22;10:1173-8. doi: 10.2147/COPD.S84225. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26150709 Free PMC article.
-
Does body height reduction influence interpretation of lung function in COPD patients?Eur Respir J. 2010 Sep;36(3):540-8. doi: 10.1183/09031936.00148609. Epub 2010 Jan 28. Eur Respir J. 2010. PMID: 20110396
-
Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.COPD. 2012 Jun;9(3):276-80. doi: 10.3109/15412555.2012.654529. Epub 2012 Feb 23. COPD. 2012. PMID: 22360379
-
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.Treat Respir Med. 2004;3(4):247-68. doi: 10.2165/00151829-200403040-00005. Treat Respir Med. 2004. PMID: 15350163 Review.
-
What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?Drugs Aging. 2008;25(9):717-28. doi: 10.2165/00002512-200825090-00001. Drugs Aging. 2008. PMID: 18729545 Review.
Cited by
-
ARTP statement on pulmonary function testing 2020.BMJ Open Respir Res. 2020 Jul;7(1):e000575. doi: 10.1136/bmjresp-2020-000575. BMJ Open Respir Res. 2020. PMID: 32631927 Free PMC article.
-
Best lung function equations for the very elderly selected by survival analysis.Eur Respir J. 2014 May;43(5):1338-46. doi: 10.1183/09031936.00100313. Epub 2014 Jan 31. Eur Respir J. 2014. PMID: 24488567 Free PMC article.
-
Impact of direct substitution of arm span length for current standing height in elderly COPD.Int J Chron Obstruct Pulmon Dis. 2015 Jun 22;10:1173-8. doi: 10.2147/COPD.S84225. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26150709 Free PMC article.
References
-
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda (MA): Global Initiative for Chronic Obstructive Lung Disease; 2010. p. 96. - PubMed
-
- Becklake MR. Concepts of normality applied to the measurement of lung function. Am J Med. 1986;80:1158–63. - PubMed
-
- Quanjer PH, Tammeling GJ, Cotes JE. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl . 1993; 16:5–40. - PubMed
-
- Sorkin JD, Muller DC, Andres R. Longitudinal change in the heights of men and women: consequential effects on body mass index. Epidemiol Rev. 1999;21:247–60. - PubMed
LinkOut - more resources
Full Text Sources